Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
11/2002
11/28/2002US20020177593 Non-carbamate amine acetylcholinesterase inhibitor and a carrier; for example, 9-amino-1,2,3,4-tetrahydroacridine or 8-(3-(1-((3-fluorophenyl)methyl)-4-piperidinyl)-1-oxopropyl)-1,2,5,6 -tetrahydro-4H-pyrrolo(3,2,1-ij)quinolin-4-one
11/28/2002US20020176992 Highly transparent non-metallic cathodes
11/28/2002CA2450535A1 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
11/28/2002CA2448531A1 Uronium and immonium salts for peptide coupling
11/28/2002CA2448080A1 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002CA2448076A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002CA2447940A1 Urazole compounds useful as anti-inflammatory agents
11/28/2002CA2447676A1 New benzylaminopyrimidines
11/28/2002CA2447675A1 Novel pyridylmethylaminopyrimidines
11/28/2002CA2447230A1 Stereoselective synthesis of 2-hydroxy-4-phenylbutyric acid esters
11/27/2002EP1259520A2 Novel purines
11/27/2002EP1259513A2 A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR
11/27/2002EP1259512A1 Pteridine compounds for the treatment of psoriasis
11/27/2002EP1259508A1 Novel biarylcarboxamides
11/27/2002EP1259493A2 Substituted piperazine compounds
11/27/2002EP1153050A4 Amino-ketone solid support templates
11/27/2002EP1115726B1 Method for preparing metalloporphyrin-metal complex conjugates
11/27/2002EP0960110B8 3-ARYL SUBSTITUTED PYRAZOLO[4,3-d]PYRIMIDINE DERIVATIVES; CORTICOTROPIN-RELEASING FACTOR RECEPTOR (CRF1) SPECIFIC LIGANDS
11/27/2002EP0915093B1 Amide derivatives
11/27/2002CN1382206A Color safe laundry methods employing zwitterionic formulation components
11/27/2002CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion
11/27/2002CN1382142A Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002CN1381454A Method for preparing oxazolidone amine
11/26/2002US6486326 iso-CBI and iso-CI analogs of CC-1065 duocarmycins
11/26/2002US6486292 Optical polyimide precursor, optical polyimide compound and fabricating method thereof
11/26/2002US6486191 Fungicidal activity
11/26/2002CA2102889C Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use
11/26/2002CA2076465C Cell binding agent conjugates of analogues and derivatives of cc-1065
11/21/2002WO2002092599A1 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-d) pyrimidine derivatives
11/21/2002WO2002092597A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.0?2,11.04.9¿)-hexadeca-2.(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002WO2002092585A1 Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
11/21/2002WO2002092089A1 Tartrate salts of 5,8,14-triazatetracyclo {10.3.1.0?2,11.04,9¿}-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002WO2002092065A2 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
11/21/2002WO2002092010A2 Reverse-turn mimetics and methods relating thereto
11/21/2002WO2002079203A8 Imidazo-triazine derivatives as pde 5 inhibitors
11/21/2002WO2002070513A9 Methods for the preparation of mirtazapine intermediates
11/21/2002WO2002062343A3 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/21/2002WO2002024226A8 Photosensitisers
11/21/2002WO2002022598A8 Quinolinone derivatives as tyrosine kinase inhibitors
11/21/2002US20020173664 An 3-acyl-4-substituted-oxazolidin-2,5-dione that readily reacts with nucleophilic reagents such as free amino acids; use in peptide synthesis for example
11/21/2002US20020173649 Chloropvrimidine intermediates
11/21/2002US20020173644 Derivatizing 1,4,8,11-tetraazacyclotetradecane or a particular acyclic tetraamine, wherein said series of steps is carried out using one solvent system; manganese complex oxidation catalysts
11/21/2002US20020173523 Immunosuppression by photochemotherapy
11/21/2002US20020173502 Enzyme inhibitor; therapy for sexual disorders
11/21/2002US20020173482 Antitumor, anticancer agents
11/21/2002US20020173468 Modified cytostatic agents
11/21/2002US20020173445 Selective androgen receptor modulators and methods for their identification, design and use
11/21/2002DE10124208A1 Use of triazolopyrimidine derivatives for protecting technical materials, particularly wood, paints and plastics, against microbes, particularly fungi
11/21/2002CA2446988A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/20/2002EP1258485A1 Method for recycling of mother liquor from a high-purity triethylenediamine production process
11/20/2002EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002EP1257553A1 Pyrrolopyrimidinone derivatives, process of preparation and use
11/20/2002EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
11/20/2002EP1042285A4 iso-CBI AND iso-CI ANALOGS OF CC-1065 AND THE DUOCARMYCINS
11/20/2002EP0925302B1 Palladium catalyzed indolization
11/20/2002EP0892780B1 M-AMIDINO PHENYL ANALOGS AS FACTOR Xa INHIBITORS
11/20/2002EP0882049B1 Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo- 4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives
11/20/2002EP0656360B1 Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same
11/20/2002CN1380883A Novel derivatives and analogues of galanthamin
11/20/2002CN1094492C Process for preparing 'Xidinafei' medicine
11/19/2002US6482949 Colormetric sensor compositions and methods
11/19/2002US6482943 Quinones as disease therapies
11/19/2002US6482825 Growth-hormone secretagogues
11/19/2002US6482819 2,3-benzodiazepine derivatives
11/19/2002US6482567 Oxime sulfonate and N-oxyimidosulfonate photoacid generators and photoresists comprising same
11/19/2002US6482429 Stable powder inhalation dosage formulation
11/19/2002CA2080097C Process for the preparation of substituted n-(aryl)-1,2,4-triazolopyrimidine-2- sulfonamides
11/14/2002WO2002090361A1 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/14/2002WO2002090359A1 Glucuronide adduct as gaba ligand
11/14/2002WO2002089808A1 Novel use of 2-phenyl-substituted imidazotriazinones
11/14/2002WO2002048146A3 Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds
11/14/2002WO2001097787A3 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
11/14/2002US20020169175 4-oxo-3,4-dihydroquinazoline or 4-oxo-pyrimidine derivatives; salt formation
11/14/2002US20020169163 1,2,3,4-tetrahydro-pyrazino(1,2-a)indole derivatives useful in treating obesity, central nerveous system diosrders, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, type II diabetes, obesity and sleep apnoea
11/14/2002US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002DE10122502A1 Purification of triethylene diamine, useful as a catalyst for the production of polyurethane foam, comprises crystallization and extraction of the resulting mother liquor with an extraction agent
11/13/2002EP1255755A1 Pyridopyrimidinone derivatives for treatment of neurodegenerative disease
11/13/2002EP1255753A2 Prodigiosin-derivatives as neoplastic and anti-viral agents
11/13/2002EP1255739A1 3-aminoquinazolin-2,4-dione antibacterial agents
11/13/2002EP1255738A2 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
11/13/2002EP1255734A1 Isatine derivatives with neurotrophic activity
11/13/2002EP1255551A1 Use of paullone derivatives for making medicines
11/13/2002EP1255550A2 Method for identifying and using a 2b adenosine receptor antagonists to mediate mammalian cell proliferation
11/13/2002EP1112272B1 Muscarinic agonists and antagonists
11/13/2002EP1107968B1 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one
11/13/2002EP1090006A4 Alkyl ether analogs of chlorins having an n-substituted imide ring
11/13/2002EP1056451B1 Bicyclic pyrrole derivatives as mcp-1 inhibitors
11/13/2002CN1379778A Process for preparation of pyrimido [5,4-g] pteridine derivatives
11/13/2002CN1379666A Non-peptide GnRH agents, methods and intermediates for their preparation
11/13/2002CN1094126C Pyrroloazepine compounds
11/12/2002US6480370 Polymeric dielectric material for high-energy density capacitors
11/12/2002US6479527 Bicyclic pyrrole derivatives as MCP-1 inhibitors
11/12/2002US6479524 To prolong the thrombin time
11/12/2002US6479514 Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
11/12/2002US6479507 Modulation of these inflammatory cytokines is considered one of the most effective strategies to block chronic inflammation and have positive therapeutic outcomes
11/12/2002US6479489 Substituted spiroheterocyclic 1H-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
11/12/2002US6479477 Substituted porphyrins
11/12/2002US6479435 Or diaryl sulfides, 1-(4-chloro-2-fluoro-5-(2-pyrimidyloxy)phenyl)-4-difluoromethy l-3-methyl-1,4-dihydro-1,2,4-triazolin-5-one for example
11/12/2002CA2103242C Imidazo[2,1-b][3]benzazepine derivatives, compositions and method of use